Navigation Links
Kaixin Jieyu Fang for treatment of vascular depression
Date:3/27/2014

The Chinese compound Kaixin Jieyu Fang can be used to treat vascular depression; however, the underlying mechanism remains unclear. Dr. Ying Zhang and co-workers from Guang'anmen Hospital, China Academy of Chinese Medical Sciences in China This study established a rat model of chronic cerebral ischemia-caused white matter damage by ligation of the bilateral common carotid arteries. Rats received daily intragastric administration of a suspension of Kaixin Jieyu Fang powder. Kaixin Jieyu Fang was made from two prescriptions of Kaixin San and Sini San supplemented with Radix Morindae Offcinalis, consisting of eight Chinese herbs including Radix Ginseng, Radix Bupleuri, Fructus Aurantii Immaturus, Radix Morindae Officinalis, Poria, Radix Polygalae, Radix Paeoniae Rubra and Radix Glycytthizae. After treatment, the degree of white matter damage in the cerebral ischemia rat model was alleviated, Bcl-2 protein and mRNA expression in brain tissue increased, and Bax protein and mRNA expression decreased. These results, published in the Neural Regeneration Research (Vol. 9, No. 1, 2014), indicate that Kaixin Jieyu Fang can alleviate cerebral white matter damage, and the underlying mechanism is associated with regulation of Bcl-2/Bax protein and mRNA expression, which is one of possible mechanism behind the protective effect of Kaixin Jieyu Fang against vascular depression.


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related medicine news :

1. Treatment helps reduce risk of esophagus disorder progressing to cancer
2. Researchers issue state-of-the-state on genetic-based testing and treatment for breast cancer
3. Twenty-five percent of breast cancer survivors report financial decline due to treatment
4. Einstein helps establish $28 million consortium to find ebola treatment
5. Chemo-free treatment a possibility for leukemia/lymphoma
6. Sepsis study comparing 3 treatment methods shows same survival rate
7. Dartmouth researchers develop new approach to chronic lymphocytic leukemia treatment
8. Gene variants protect against relapse after treatment for hepatitis C
9. PSA-testing and early treatment decreases risk of prostate cancer death
10. Emerging multi-drug resistant infections lack standard definition and treatment
11. Making treatment of rare blood disorder more affordable and effective
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Kaixin Jieyu Fang for treatment of vascular depression
(Date:5/4/2016)... ... May 04, 2016 , ... International ... scheduled on July 25-27, 2016 at Las Vegas. It aims to bring together ... educational institutes and research organizations across the globe; making the conference a perfect ...
(Date:5/4/2016)... ... May 04, 2016 , ... Netc , a leading provider of barcode ... Style Printing, Inc. The Dataware acquisition enables Netc to continue to grow its label business, ... Label Stock provides customers with the ability to print and label tape media on site ...
(Date:5/3/2016)... ... May 04, 2016 , ... ... That message is reaching the global health community through expanding activities that embrace ... of cancer in the resource-limited countries. , In support of this ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ProIntro Glitch is ... Pro X. Pixel Film Studios’ titles allow users to add a terrifying opener to ... such as boxes, lines and accents. To add greater contrast, all the user has ...
(Date:5/3/2016)... ... May 03, 2016 , ... In April, Amerec launched ... latest technologies to help find the best steam and sauna solutions. , First, the ... responsive design. This improvement brings all of the site’s features, especially the Steam ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... , May 2, 2016 Leading Economies with Fastest ... 10.2 Côte d,Ivoire 8.6 Uzbekistan 8 Ireland 7.8 India 7.3, , ... BRICS nations , which comprises of Brazil , ... and South Africa , registered the fastest GDP growth ... in China , recession in Brazil ...
(Date:5/2/2016)... N.J. , May 2, 2016  Celsion ... development company, today announced data from the first ... escalating clinical trial (the OVATION Study) combining GEN-1, ... care for the treatment of newly-diagnosed patients with ... followed by interval debulking surgery.  In the first ...
(Date:4/29/2016)... PUNE, India , April 29, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" market research report ... pipeline, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ... press releases. It also reviews key players involved ...
Breaking Medicine Technology: